-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Regeneron Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q1 2019 to Q4 2023.
- Regeneron Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending December 31, 2023 was $12.4M.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)